32032698 28420983 30026371 34663684 36415932 32523507 31761667 33007689 29308544 32103062 31517532 28674978 29513927 32410948 33706934 32691280 28239348 32848606 27181083 30643711 28353278 29321258 34439767 29550548 31149340 31969802 29074404 3297556 - Search Results

Year	Number of Results
2016	10
2017	18
2018	16
2019	21
2020	21
2021	21
2022	10
2023	1

1

Inhibition of Lrrk2 reduces ethanol preference in a model of acute exposure in zebrafish.

Paiva IM, de Carvalho LM, Di Chiaccio IM, Lima Assis I, Naranjo ES, Bernabé MG, Ferreira FNA, Cayuela ML, Murgas LDS, Brunialti Godard AL. Paiva IM, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jun 8;100:109885. doi: 10.1016/j.pnpbp.2020.109885. Epub 2020 Feb 4. Prog Neuropsychopharmacol Biol Psychiatry. 2020. PMID: 32032698

2

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson's Disease-Associated LRRK2 Gene Mutations.

Loeffler DA, Klaver AC, Coffey MP, Aasly JO, LeWitt PA. Loeffler DA, et al. Front Aging Neurosci. 2017 Apr 3;9:89. doi: 10.3389/fnagi.2017.00089. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28420983 Free PMC article.

3

Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

Macdonald R, Barnes K, Hastings C, Mortiboys H. Macdonald R, et al. Biochem Soc Trans. 2018 Aug 20;46(4):891-909. doi: 10.1042/BST20170501. Epub 2018 Jul 19. Biochem Soc Trans. 2018. PMID: 30026371 Free article. Review.

4

Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection.

Pirooznia SK, Rosenthal LS, Dawson VL, Dawson TM. Pirooznia SK, et al. Pharmacol Rev. 2021 Oct;73(4):33-97. doi: 10.1124/pharmrev.120.000189. Pharmacol Rev. 2021. PMID: 34663684 Review.

5

Possible association between the lrrk2 gene and anxiety behavior: a systematic literature review.

Moreira-Júnior RE, Souza RM, de Carvalho JG, Bergamini JP, Brunialti-Godard AL. Moreira-Júnior RE, et al. J Neurogenet. 2022 Sep-Dec;36(4):98-107. doi: 10.1080/01677063.2022.2144293. Epub 2022 Nov 22. J Neurogenet. 2022. PMID: 36415932

6

"LRRK2: Autophagy and Lysosomal Activity".

Madureira M, Connor-Robson N, Wade-Martins R. Madureira M, et al. Front Neurosci. 2020 May 25;14:498. doi: 10.3389/fnins.2020.00498. eCollection 2020. Front Neurosci. 2020. PMID: 32523507 Free PMC article. Review.

7

Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics.

Senkevich K, Gan-Or Z. Senkevich K, et al. Parkinsonism Relat Disord. 2020 Apr;73:60-71. doi: 10.1016/j.parkreldis.2019.11.015. Epub 2019 Nov 17. Parkinsonism Relat Disord. 2020. PMID: 31761667 Review.

8

Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model.

Castro-Sánchez S, Zaldivar-Diez J, Luengo E, López MG, Gil C, Martínez A, Lastres-Becker I. Castro-Sánchez S, et al. Neurobiol Aging. 2020 Dec;96:148-154. doi: 10.1016/j.neurobiolaging.2020.09.006. Epub 2020 Sep 8. Neurobiol Aging. 2020. PMID: 33007689 Free article.

9

The LRRK2 signalling system.

Price A, Manzoni C, Cookson MR, Lewis PA. Price A, et al. Cell Tissue Res. 2018 Jul;373(1):39-50. doi: 10.1007/s00441-017-2759-9. Epub 2018 Jan 8. Cell Tissue Res. 2018. PMID: 29308544 Free PMC article. Review.

10

In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets.

Vermilyea SC, Babinski A, Tran N, To S, Guthrie S, Kluss JH, Schmidt JK, Wiepz GJ, Meyer MG, Murphy ME, Cookson MR, Emborg ME, Golos TG. Vermilyea SC, et al. Sci Rep. 2020 Feb 26;10(1):3447. doi: 10.1038/s41598-020-60273-2. Sci Rep. 2020. PMID: 32103062 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results